Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3
Humana, Cencora and Globus Medical are poised to outshine in the September quarter, driven by strong demand, innovation and volume…
83,890$
35,94%
Echtzeit-Aktienkurs Globus Medical
Bid:
Ask:
Nachrichten zur Globus Medical Aktie
Paradice Dumped Its Entire $15.2 Million Progressive Software Stake
Key PointsSold 238,145 shares, with the estimated transaction value of $15.20 millionThis change represented 3.41% of reportable 13F assets under…
Paradice Investment Management Liquidates Its $20 Million Nomad Foods (NYSE: NOMD) Position: Is the Stock in Trouble?
Key PointsParadice sold 1,204,570 shares, with an estimated transaction value of $20.47 million based on average pricing during the quarter…
Globus Medical – Medizintechnik-Spezialist profitiert von demographischen Wandel
Geschäftstreiber: Globus Medical (GMED) gehört zu den führenden Anbietern im Bereich orthopädische Implantate und deckt dabei die Bereiche Wirbelsäule, Trauma…
Globus Medical (GMED) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Globus Medical (GMED) give a sense of how its business performed in the quarter…
Globus Medical (GMED) Beats Q2 Earnings and Revenue Estimates
Globus Medical (GMED) delivered earnings and revenue surprises of +13.16% and +0.49%, respectively, for the quarter ended June 2025. Do…
Globus Medical stock hits 52-week low at 53.54 USD By Investing.com
Globus Medical stock hits 52-week low at 53.54 USD…
GMED Unveils Next-Gen Oscillating System DuraPro: Stock to Gain?
Globus Medical debuts DuraPro with Excelsius integration, boosting its Power Portfolio.…
Globus Medical: Obtaining My Backing Again
…
Globus Medical (GMED) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended March 2025,…
Globus Medical (GMED) Lags Q1 Earnings and Revenue Estimates
Globus Medical (GMED) delivered earnings and revenue surprises of -8.11% and 4.81%, respectively, for the quarter ended March 2025. Do…
Gear Up for Globus Medical (GMED) Q1 Earnings: Wall Street Estimates for Key Metrics
Beyond analysts top -and-bottom-line estimates for Globus Medical (GMED), evaluate projections for some of its key metrics to gain a…
Globus Medical (GMED) Earnings Expected to Grow: Should You Buy?
Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming…
Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?
Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…
International Growth Drives GMED Stock Amid Fierce Competition
Globus Medical is gearing up for a series of product launches throughout the Musculoskeletal portfolio in the coming months of…
Globus Medical completes acquisition of Nevro Corp.
AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today…
GMED Stock Jumps 41.8% in a Year: Whats Behind the Rally?
Globus Medicals robust musculoskeletal offerings and synergies from the NuVasive merger are fueling its stock gains.…
Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference
Monday, March 10, 2025 at 4:30 pm Pacific Time Monday, March 10, 2025 at 4:30 pm Pacific Time…
Globus Medical (GMED) Q4 2024 Earnings Call Transcript
GMED earnings call for the period ending December 31, 2024.…